5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Automated External Defibrillator
The Automated External Defibrillator (AED) stands as a critical life-saving device designed to provide immediate assistance in the event of sudden cardiac arrest. Compact and user-friendly, an AED is engineered to be accessible to individuals with minimal training, allowing bystanders to take swift action in emergency situations. Its automated functionality guides users through each step, from electrode placement to analyzing the heart rhythm, ensuring that timely and effective defibrillation is administered. These devices have become integral in public spaces, workplaces, and community settings, enhancing the chances of survival for those experiencing cardiac emergencies. As a vital component of modern emergency response systems, the Automated External Defibrillator exemplifies innovation in healthcare technology, contributing to increased preparedness and improved outcomes in critical situations
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain